| In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19 C Sachdeva, A Wadhwa, A Kumari, F Hussain, P Jha, NK Kaushik OMICS: A Journal of Integrative Biology 24 (10), 568-580, 2020 | 53 | 2020 |
| Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy AP Bidkar, S Wang, KN Bobba, E Chan, S Bidlingmaier, EA Egusa, ... Clinical Cancer Research 29 (10), 1916-1928, 2023 | 16 | 2023 |
| Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics KN Bobba, AP Bidkar, N Meher, C Fong, A Wadhwa, S Dhrona, A Sorlin, ... Journal of Nuclear Medicine 64 (7), 1076-1082, 2023 | 12 | 2023 |
| Virtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication A Anju, S Chaturvedi, V Chaudhary, P Pant, F Hussain, AK Mishra Journal of Biomolecular Structure and Dynamics 40 (18), 8464-8493, 2022 | 6 | 2022 |
| Microenvironment stimulated bioresponsive small molecule carriers for radiopharmaceuticals S Chaturvedi, PP Hazari, A Kaul, Anju, AK Mishra ACS omega 5 (41), 26297-26306, 2020 | 4 | 2020 |
| Design, physico-chemical and pre-clinical evaluation of a homo-bivalent 99m Tc-(BTZ) 2 DTPA radioligand for targeting dimeric 5-HT 1A/5-HT 7 receptors P Jha, S Chaturvedi, A Kaul, P Pant, S Pal, N Jain, AK Mishra New Journal of Chemistry 42 (18), 15032-15043, 2018 | 4 | 2018 |
| Acetylated Benzothiazolone as Homobivalent SPECT Metallo-Radiopharmaceutical 99mTc-(6-AcBTZ)2DTPA: Design, Synthesis, and Preclinical Evaluation for Mapping 5 … P Jha, S Chaturvedi, Anju, A Kaul, N Jain, AK Mishra ACS omega 4 (6), 10044-10055, 2019 | 3 | 2019 |
| CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma A Wadhwa, S Wang, B Patiño-Escobar, AP Bidkar, KN Bobba, E Chan, ... Clinical Cancer Research 30 (5), 1009-1021, 2024 | 2 | 2024 |
| 5-HT1A targeting PARCEST agent DO3AM-MPP with potential for receptor imaging: Synthesis, physico-chemical and MR studies Anju, S Chaturvedi, V Chaudhary, P Pant, P Jha, SS Kumaran, F Hussain, ... Bioorganic Chemistry 106, 104487, 2021 | 2 | 2021 |
| Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5 KN Bobba, AP Bidkar, A Wadhwa, N Meher, S Drona, AM Sorlin, ... Theranostics 14 (4), 1344, 2024 | 1 | 2024 |
| Design, development and bio-evaluation of a novel radio-ligand 99mTc-THQ-DTPA as a sigma 2 receptor specific breast tumor imaging agent V Chaudhary, S Chaturvedi, A Wadhwa, R Chaudhary, D Gautam, ... Bioorganic & Medicinal Chemistry 97, 117515, 2024 | | 2024 |
| Alpha particle therapy for the treatment of metastatic tumors of prostate cancer A Bidkar, A Wadhwa, K Bobba, N Meher, S Bidlingmaier, E Egusa, U Ali, ... Nuclear Medicine and Biology 126, 108749, 2023 | | 2023 |
| StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery N Meher, G Ashley, A Bidkar, A Wadhwa, K Bobba, S Dhrona, S Fontaine, ... Nuclear Medicine and Biology 126, 108640, 2023 | | 2023 |
| StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy A Bidkar, N Meher, G Ashley, A Wadhwa, K Bobba, B Shuere, D Wilson, ... Nuclear Medicine and Biology 126, 108400, 2023 | | 2023 |
| Molecular imaging and radiopharmaceutical therapy of Multiple Myeloma targeting CD46 using 89Zr and 225Ac-YS5 A Wadhwa, S Wang, B Escobar, A Bidkar, K Bobba, N Meher, S Dhrona, ... Nuclear Medicine and Biology 126, 108473, 2023 | | 2023 |
| Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics K Bobba, A Bidkar, N Meher, C Fong, A Wadhwa, S Dhrona, A Sorlin, ... Nuclear Medicine and Biology 126, 108410, 2023 | | 2023 |
| Evaluation of134Ce/134La as a PET Imaging Theranostic Pair for225Ac α-Radiotherapeutics KN Bobba, AP Bidkar, N Meher, C Fong, A Wadhwa, S Dhrona, A Sorlin, ... Journal of Nuclear Medicine 64 (7), 2023 | | 2023 |
| Niranjan Meher Cyclic [68Ga] and [18F] AlF-labeled peptides for specific detection of human angiotensin-converting enzyme 2 RF David Wilson, Anju Anju, Matthew Parker, Niranjan Meher, Joseph Blecha ... Nuclear Medicine and Biology 114, S64-S65, 2022 | | 2022 |
| Nanotechnology-Based Therapeutics in ROS-Induced Cancer HM Berehu, S Anupriya, S Patnaik Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 1-20, 2022 | | 2022 |
| Design, synthesis and bivalent approach for evaluation of prostate specific membrane antigen inhibitor 99mTc-DTPA- (Glu-urea-Lys)2 for single-photon emission … A Wadhwa, S Chaturvedi, V Chaudhary, F Hussain, AK Mishra Indian Journal of Nuclear Medicine 34 (5, suppl. 1), 86, 2019 | | 2019 |
